Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Functional molecules in allergic bronchial asthma].

Hiroyuki Tanaka1

  • 1Department of Pharmacology, Gifu Pharmaceutical University, 5-6-1 Mitahora-Higashi, Gifu 502-8585, Japan. hirotnk@gifu-ppu.ac.jp

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|September 19, 2002
PubMed
Summary

Targeting single factors like IL-4 or IL-5 is less effective for allergic asthma than broad suppression. Multifunctional molecules offer a better strategy for managing this complex airway inflammation and hyperresponsiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of iriflophenone 3-C-β-d-glucoside from Aquilaria spp. by an indirect competitive enzyme-linked immunosorbent assay using a specific polyclonal antibody.

Journal of food science·2013
Same author

A case of cancer of the ampulla of Vater accompanied by malrotation.

The Kurume medical journal·2013
Same author

MLL2 and KDM6A mutations in patients with Kabuki syndrome.

American journal of medical genetics. Part A·2013
Same author

Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-κB and spleen tyrosine kinase activation.

Investigative ophthalmology & visual science·2013
Same author

Study of 1,3,5-triazine-based catalytic amide-forming reactions: effect of solvents and basicity of reactants.

Chemical & pharmaceutical bulletin·2013
Same author

Treatment of the chronic itch of atopic dermatitis using standard drugs and kampo medicines.

Biological & pharmaceutical bulletin·2013

Area of Science:

  • Immunology
  • Pulmonology
  • Allergy

Context:

  • Bronchial asthma is a chronic inflammatory airway disease marked by obstruction and hyperresponsiveness.
  • Allergen-induced airway hyperresponsiveness (AHR) mechanisms are not fully understood.
  • In vivo models are crucial for studying asthma pathogenesis.

Purpose:

  • To investigate the role of inflammatory cells and molecules in allergen-induced AHR using a mouse asthma model.
  • To elucidate the specific contributions of T cells, mast cells, and Th2 cytokines (IL-4, IL-5) to AHR.

Summary:

  • A mouse model of allergic asthma demonstrated airway eosinophilia, IgE, Th2 cytokines, and AHR.
  • Gene-knockout studies implicated T cells, mast cells, prostanoids, IL-4, and IL-5 in allergen-induced AHR.

Related Experiment Videos

  • Monoclonal antibodies targeting IL-4 or IL-5 alone did not inhibit AHR, but combined treatment did.

    • Impact:

    • Asthma management may benefit more from targeting multifunctional molecules (e.g., corticosteroids) than single factors.
    • Highlights the multifactorial nature of bronchial asthma, suggesting broader therapeutic strategies.
    • Provides insights into the complex inflammatory pathways driving allergic airway hyperresponsiveness.